Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Liposomal benzoquinazoline thymidylate synthase inhibitor formulations

Liposomal benzoquinazoline thymidylate synthase inhibitor formulations

US Patent 6689381 · Granted Feb 10, 2004

Estimated economic value: $15,956,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System and method for assessing quality of medical images2025
Phospholipid formulations of 1′-cyano substituted carba-nucleoside analogs2025
Biologically active taxane analogs and methods of treatment by oral administrati2024
Taxane analogs for the treatment of brain cancer2023
Biologically active taxane analogs and methods of treatment by oral administrati2022
Multi-level indexing of backup files2022
Taxane analogs for the treatment of brain cancer2021
Biologically active taxane analogs and methods of treatment by oral administrati2020
Biologically active taxane analogs and methods of treatment by oral administrati2019
Taxane analogs for the treatment of brain cancer2018
Method of deploying applications rapidly based on customized android platform2018
Biologically active taxane analogs and methods of treatment by oral administrati2017